ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 62 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2019. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -64.1% | 12,208 | -72.4% | 0.00% | -71.4% |
| Q4 2022 | $103 | -99.9% | 44,194 | -16.2% | 0.01% | +16.7% |
| Q2 2022 | $143,000 | -49.3% | 52,722 | -43.4% | 0.01% | -55.6% |
| Q2 2021 | $282,000 | +32.4% | 93,196 | +45.8% | 0.03% | +80.0% |
| Q1 2021 | $213,000 | -4.1% | 63,941 | +2.3% | 0.02% | -37.5% |
| Q4 2020 | $222,000 | +616.1% | 62,530 | +264.7% | 0.02% | +500.0% |
| Q2 2020 | $31,000 | -39.2% | 17,147 | -30.1% | 0.00% | +33.3% |
| Q2 2019 | $51,000 | -10.5% | 24,548 | +117.5% | 0.00% | 0.0% |
| Q4 2017 | $57,000 | – | 11,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |